Table 2.
Linear regression models to explore a specific clinical or laboratory item associated with Cyr61.
| Analytical data | β Coefficient | 95% CI | p |
|---|---|---|---|
| Univariate analysis | |||
| Fever | −60.423 | (−90.163, −30.684) | 0.000 |
| Arthralgia | −52.679 | (−83.418, −21.939) | 0.001 |
| Arthritis | 4.558 | (−47.204, 56.320) | 0.861 |
| Skin rash | −43.682 | (−75.057, −12.306) | 0.007 |
| Sore throat | −52.814 | (−83.204, −22.425) | 0.001 |
| Lymphadenopathy | −30.018 | (−62.330, 2.294) | 0.068 |
| Splenomegaly | −27.595 | (−65.289, 10.099) | 0.148 |
| Hepatomegaly | −68.172 | (−196.765, 60.420) | 0.293 |
| Pericarditis | −4.630 | (−53.510, 44.251) | 0.850 |
| Pleuritis | −26.179 | (−70.244, 17.887) | 0.239 |
| Pneumonia | −21.499 | (−56.780, 13.783) | 0.227 |
| Myalgia | −13.684 | (−52.818, 25.449) | 0.487 |
| Systemic score | −7.627 | (−12.781, −2.472) | 0.004 |
| Leukocyte, × 109/L | −64.322 | (−98.934, −29.709) | 0.001 |
| ESR, mm/h | −0.303 | (−0.771, 0.165) | 0.200 |
| CRP, mg/L | −0.005 | (−0.291, 0.280) | 0.971 |
| Ferritin, ng/ml | −0.003 | (−0.009, 0.004) | 0.414 |
| IL−10, pg/ml | 3.882 | (−0.881, 8.645) | 0.108 |
| IL−1β, pg/ml | −22.028 | (−64.310, 20.255) | 0.301 |
| IL−6, pg/ml | −0.402 | (−1.381, 0.578) | 0.415 |
| TNF–a, pg/ml | 0.252 | (−2.815, 3.318) | 0.870 |
| IL−18, ng/ml | −0.027 | (−0.095, 0.040) | 0.424 |
| Multivariate analysis | |||
| Fever | −4.416 | (−141.063, −7.770) | 0.029 |
| Arthralgia | 4.340 | (−50.373, 59.054) | 0.874 |
| Skin rash | −17.042 | (−67.220, 33.136) | 0.498 |
| Sore throat | −29.668 | (−68.442, 9.106) | 0.131 |
| Systemic score | 12.140 | (−0.158, 24.438) | 0.053 |
| Leukocyte, × 109/L | −3.416 | (−6.588, −0.244) | 0.035 |
CRP, C-reactive protein; ESR, erythrocyte sedimentation rate.